当前位置: 首页 > 期刊 > 《世界中医药》 > 20187
编号:13593142
关于“结肠黑变病”的商榷(5)
http://www.100md.com 2018年4月1日 《世界中医药》 20187
     [31]Weinberg DS,Smalley W,Heidelbaugh JJ,et al.American Gastroenterological Association Institute Guideline on the Use of Pharmacological Therapies in the Treatment of Irritable Bowel Syndrome[J].Gastroenterology,2014,147(5):1146.

    [32]Camilleri M,Drossman DA,Becker G,et al.Emerging treatments in neurogastroenterology:a multidisciplinary working group consensus statement on opioidinduced constipation[J].Neurogastroenterology & Motility the Official Journal of the European Gastrointestinal Motility Society,2014,26(10):1386.

    [33]Tabbers M M,Dilorenzo C,Berger MY,et al.Evaluation and treatment of functional constipation in infants and children:evidencebased recommendations from ESPGHAN and NASPGHAN[J].Journal of Pediatric Gastroenterology&Nutrition,2014,58(2):258.

    [34]Bharucha AE,Pemberton J H.American Gastroenterological Association technical review on constipation[J].Gastroenterology,2013,144(1):21838.

    [35]Harris A,Buchanan GN.Melanosis coli is reversible[J].Colorectal Disease the Official Journal of the Association of Coloproctology of Great Britain&Ireland,2009,11(7):788789.

    (2018-07-04收稿責任编辑:张文婷), http://www.100md.com(倪涛 张漫 唐庆)
上一页1 2 3 4 5